Market Size of United States Probiotics Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 13.50 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Probiotics Market Analysis
The United States probiotics market is projected to register a CAGR of 13.5% during the forecast period (2022-2027).
The COVID-19 pandemic has had a greater impact on the shift in consumption patterns of consumers as their health consciousness among them has increased. Consumers in the US started to avoid junk or processed foods and look for health-beneficial and nutritive foods and products. The sales of probiotic products in the US increased by 33% since the pandemic, as the consumers are inclined toward nutrient boosters to improve their immunity. Since then, the demand for probiotic products in the US has increased drastically. As all age groups are vulnerable to the virus, manufacturers are designing probiotic products that can have effective results for every individual.
Over the medium term, increasing health consciousness and the consumers' preference for nutritive foods are expected to drive the market. Probiotics are a driving force within the booming digestive health supplement category, and they are being consumed by people of all age groups. However, the major consumption is observed among the millennials, due to the growing awareness about health and wellness through multi-channel publicity, which has influenced their consumption pattern to a large extent.
The healthcare expenditure pattern in the country is rising with the growing geriatric population, advanced technology, better medical facilities, and a rise in the number of insured people. These factors are, in turn, driving the overall sale of probiotics in the country.However, high R&D costs for developing new probiotic strains, high initial investments, and high prices of the products are expected to slow down the markets growth.
